MEDICAL MANAGEMENT OF PARKINSON'S DISEASE

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2002-03, Vol.72 (suppl 1), p.i22-27
1. Verfasser:	Clarke, C E
Format:	Artikel
Sprache:	eng
Schlagworte:	6-tetrahydropyridine Amantadine - adverse effects Amantadine - therapeutic use Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Cholinergic Antagonists - adverse effects Cholinergic Antagonists - therapeutic use Clinical Trials as Topic COMT: catechol-O-methyltransferase DATATOP: deprenyl and tocopherol antioxidant therapy of parkinsonism Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Delayed-Action Preparations dopamine agonists Dopamine Agonists - adverse effects Dopamine Agonists - therapeutic use early Parkinson's disease ELLDOPA: earlier versus later levodope Humans later Parkinson's disease levodopa Levodopa - adverse effects Levodopa - therapeutic use MAOB: monoamine oxidase B Medical sciences MPTP: 1-methyl-4-phenyl-1 Neurologic Examination - drug effects Neurology Neurology in Practice Neuropharmacology neuroprotection Neuroprotective Agents - adverse effects Neuroprotective Agents - therapeutic use Parkinson Disease - diagnosis Parkinson Disease - drug therapy Parkinson's disease PET: positron emission tomography Pharmacology. Drug treatments RCT: randomised controlled trial UPDRS: unified Parkinson's disease rating scale
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0022-3050 1473-7086 1468-330X
DOI:	10.1136/jnnp.72.suppl_1.i22